Komori
Astena Holdings (8095) · RiskMaterialised

Recognition of Valuation Losses on Investment Securities Held

First written in FY2022. 6 of 6 entries say "Materialised", first in FY2022. Latest entry: FY2024.

6entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2022 – FY20242023: 320232024: 220242025: 12025
Same theme, other companies
Recognition of Valuation Losses on Investment Securities and Shares in Affiliated CompaniesA theme 207 companies write about · 217 as a headwind · 0 as a tailwind

Astena Holdings moved to the "Worse" side of this theme in 2023, 1 year after the typical company in this theme (2022).

The whole theme swung hardest in 2017: 8 of 23 companies on the "Worse" side.

24 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 218 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024MaterialisedAnnual report

    「In the consolidated fiscal year, impairment losses of ¥246.695 million were recognized on securities, all of which were other securities.」

    Following a decline in the substantial value of investment securities, an impairment loss of ¥246.695 million was recorded.
  2. FY2024-Q2MaterialisedAnnual report

    「Impairment loss on investment securities 98,550」

    Following a significant decline in the substantial value of investment securities, an impairment loss of ¥98.55 million was recorded in the cumulative second quarter.
  3. FY2024-Q1MaterialisedAnnual report

    「Impairment loss on investment securities 50,573 The impairment loss on investment securities resulted from impairment testing of securities classified as investment securities and held by the Company's consolidated subsidiaries whose substantial value had declined significantly.」

    Following a significant decline in the substantial value of investment securities, an impairment loss of ¥50.573 million was recorded in the first quarter.
  4. FY2023-Q3MaterialisedAnnual report

    「Impairment loss on investment securities 219,351」

    Securities whose substantial value had declined significantly were impaired, and an impairment loss of ¥219.351 million was recorded on investment securities.
  5. FY2023-Q2MaterialisedAnnual report

    「The impairment loss on investment securities resulted from impairment testing of securities classified as investment securities and held by the Company's consolidated subsidiaries whose substantial value had declined significantly.」

    The substantial value of investment securities held by consolidated subsidiaries declined significantly, and an impairment loss of ¥216.728 million was recorded in the cumulative second quarter.
  6. FY2022MaterialisedAnnual report

    「In the consolidated fiscal year, impairment losses of ¥303.543 million were recognized on securities, all of which were other securities.」

    An impairment loss of ¥303.543 million was recorded on investment securities held by the Company because their substantial value had declined significantly.
Moved together

"Risk of Business Suspension Due to Natural Disasters, Accidents and Terrorism" moved the same way as this thread, in the same document, in 4 of its 6 moves.

433222★123456
  1. ★This thread
  2. 1Risk of Business Suspension Due to Natural Disasters, Accidents and Terrorism4×
  3. 22025 Vision and First Three-Year Plan for Growth and Higher Corporate Value3×
  4. 3Earnings Pressure on the Pharmaceutical Business from Drug Price Revisions3×
  5. 4Revenue and profit growth in the Pharmaceutical and Franchise Businesses2×
  6. 5Sharp Decline in Chemicals Business Revenue and Widening Operating Loss2×
  7. 6Decline in Consolidated Net Sales, Increase in Operating Income, and Shift to Profitability2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Astena Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recognition of Valuation Losses on Investment Securities Held | Astena Holdings Co.,Ltd. (8095) | Komori